Corient Private Wealth’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236K Buy
10,257
+2,189
+27% +$68.2K ﹤0.01% 2458
2025
Q4
$355K Buy
8,068
+134
+2% +$7.52K ﹤0.01% 2465
2025
Q3
$580K Buy
7,934
+3,687
+87% +$240K ﹤0.01% 1712
2025
Q2
$261K Sell
4,247
-6,965
-62% -$389K ﹤0.01% 2076
2025
Q1
$651K Buy
11,212
+2,325
+26% +$147K ﹤0.01% 1470
2024
Q4
$474K Buy
8,887
+334
+4% +$16.4K ﹤0.01% 1651
2024
Q3
$373K Sell
8,553
-424
-5% -$14.1K ﹤0.01% 1906
2024
Q2
$251K Sell
8,977
-35,880
-80% -$946K ﹤0.01% 2007
2024
Q1
$1.21M Buy
44,857
+182
+0.4% +$5.19K ﹤0.01% 1248
2023
Q4
$1.25M Sell
44,675
-6,572
-13% -$155K ﹤0.01% 1204
2023
Q3
$1.09M Buy
51,247
+41,842
+445% +$1.14M ﹤0.01% 1162
2023
Q2
$320K Sell
9,405
-32,450
-78% -$1.08M ﹤0.01% 1666
2023
Q1
$1.36M Buy
41,855
+373
+0.9% +$12.4K ﹤0.01% 977
2022
Q4
$1.39M Buy
+41,482
New +$1.27M 0.01% 813

Other funds holding DOCS

Corient Private Wealth's DOCS Position: Q1 2026 in Review

Corient Private Wealth increased its Doximity (DOCS) stake by 27% in Q1 2026, buying an estimated $68.2K and bringing the position to 10,257 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #2458.

Corient Private Wealth first reported a position in DOCS in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.39M in Q4 2022. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Corient Private Wealth held 10,257 shares of Doximity worth $236K as of Q1 2026.
  • Corient Private Wealth bought 2,189 Doximity shares in Q1 2026, an estimated $68.2K.
  • Doximity made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2458 holding.
  • Corient Private Wealth first reported a position in Doximity in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Doximity position peaked at $1.39M in Q4 2022.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.